Benito A - Search Results

1

Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized Protocol.

Fernández R, Carreño A, Mendoza R, Benito A, Ferrer-Miralles N, Céspedes MV, Corchero JL. Fernández R, et al. Among authors: benito a. Int J Mol Sci. 2022 Dec 8;23(24):15543. doi: 10.3390/ijms232415543. Int J Mol Sci. 2022. PMID: 36555185 Free PMC article.

2

All-in-one biofabrication and loading of recombinant vaults in human cells.

Martín F, Carreño A, Mendoza R, Caruana P, Rodriguez F, Bravo M, Benito A, Ferrer-Miralles N, Céspedes MV, Corchero JL. Martín F, et al. Among authors: benito a. Biofabrication. 2022 Mar 9;14(2). doi: 10.1088/1758-5090/ac584d. Biofabrication. 2022. PMID: 35203066

3

Generation of new cytotoxic human ribonuclease variants directed to the nucleus.

Vert A, Castro J, Ruiz-Martínez S, Tubert P, Escribano D, Ribó M, Vilanova M, Benito A. Vert A, et al. Among authors: benito a. Mol Pharm. 2012 Oct 1;9(10):2894-902. doi: 10.1021/mp300217b. Epub 2012 Sep 20. Mol Pharm. 2012. PMID: 22957849

4

Production of engineered human pancreatic ribonucleases, solving expression and purification problems, and enhancing thermostability.

Canals A, Ribó M, Benito A, Bosch M, Mombelli E, Vilanova M. Canals A, et al. Among authors: benito a. Protein Expr Purif. 1999 Oct;17(1):169-81. doi: 10.1006/prep.1999.1112. Protein Expr Purif. 1999. PMID: 10497083

5

A truncated apoptin protein variant selectively kills cancer cells.

Ruiz-Martínez S, Castro J, Vilanova M, Bruix M, Laurents DV, Ribó M, Benito A. Ruiz-Martínez S, et al. Among authors: benito a. Invest New Drugs. 2017 Jun;35(3):260-268. doi: 10.1007/s10637-017-0431-6. Epub 2017 Jan 24. Invest New Drugs. 2017. PMID: 28120180

6

Mini-review: nucleus-targeted ribonucleases as antitumor drugs.

Castro J, Ribó M, Benito A, Vilanova M. Castro J, et al. Among authors: benito a. Curr Med Chem. 2013;20(10):1225-31. doi: 10.2174/0929867311320100003. Curr Med Chem. 2013. PMID: 23432583 Review.

7

A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation.

Castro J, Ribó M, Navarro S, Nogués MV, Vilanova M, Benito A. Castro J, et al. Among authors: benito a. BMC Cancer. 2011 Jan 11;11:9. doi: 10.1186/1471-2407-11-9. BMC Cancer. 2011. PMID: 21223552 Free PMC article.

8

Bactericidal activity engineered on human pancreatic ribonuclease and onconase.

Torrent G, Ribó M, Benito A, Vilanova M. Torrent G, et al. Among authors: benito a. Mol Pharm. 2009 Mar-Apr;6(2):531-42. doi: 10.1021/mp8001914. Mol Pharm. 2009. PMID: 19718804

9

Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.

Pous J, Canals A, Terzyan SS, Guasch A, Benito A, Ribó M, Vilanova M, Coll M. Pous J, et al. Among authors: benito a. J Mol Biol. 2000 Oct 13;303(1):49-60. doi: 10.1006/jmbi.2000.4506. J Mol Biol. 2000. PMID: 11021969

10

Purification of engineered human pancreatic ribonuclease.

Ribó M, Benito A, Canals A, Nogués MV, Cuchillo CM, Vilanova M. Ribó M, et al. Among authors: benito a. Methods Enzymol. 2001;341:221-34. doi: 10.1016/s0076-6879(01)41154-2. Methods Enzymol. 2001. PMID: 11582779 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

636 results

Search Page